Medical University of Innsbruck
Innsbruck, Austria
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Non-small Cell Lung Cancer
Boehringer Ingelheim400 enrolled192 locationsNCT07195695
Recruiting
Phase 2
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Gilead Sciences176 enrolled129 locationsNCT06029972
Recruiting
Phase 4
HOPE Against Cancer Recurrence in HCC
HCCLiver TransplantationOncological Outcomes
Philipp Dutkowski220 enrolled37 locationsNCT06717919
Recruiting
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Ulcerative Colitis (UC)IBD-unclassified (IBD-U)
Medical University Innsbruck120 enrolled10 locationsNCT06954311